Correlation Between Tarsus Pharmaceuticals and Summit Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Summit Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Summit Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Summit Therapeutics PLC, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Summit Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Summit Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Summit Therapeutics.
Diversification Opportunities for Tarsus Pharmaceuticals and Summit Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tarsus and Summit is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Summit Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Summit Therapeutics PLC and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Summit Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Summit Therapeutics PLC has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Summit Therapeutics go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Summit Therapeutics
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to under-perform the Summit Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Tarsus Pharmaceuticals is 1.62 times less risky than Summit Therapeutics. The stock trades about -0.17 of its potential returns per unit of risk. The Summit Therapeutics PLC is currently generating about 0.28 of returns per unit of risk over similar time horizon. If you would invest 1,821 in Summit Therapeutics PLC on October 28, 2024 and sell it today you would earn a total of 555.00 from holding Summit Therapeutics PLC or generate 30.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Summit Therapeutics PLC
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Summit Therapeutics PLC |
Tarsus Pharmaceuticals and Summit Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Summit Therapeutics
The main advantage of trading using opposite Tarsus Pharmaceuticals and Summit Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Summit Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Summit Therapeutics will offset losses from the drop in Summit Therapeutics' long position.| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
| Summit Therapeutics vs. Nkarta Inc | Summit Therapeutics vs. Cullinan Oncology LLC | Summit Therapeutics vs. Kezar Life Sciences | Summit Therapeutics vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |